MedPath

Hucircadian

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning

Not Applicable
Completed
Conditions
Major Depressive Disorder
Bipolar 1 Disorder
Bipolar II Disorder
First Posted Date
2022-06-02
Last Posted Date
2025-03-17
Lead Sponsor
Hucircadian
Target Recruit Count
93
Registration Number
NCT05400785
Locations
🇰🇷

Korea University Anam Hospital, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.